What did AstraZenecas marketing materials for Nexium claim?
According to the complaint, AstraZeneca promoted Nexium as the “first PPI to offer significant clinical improvements over Losec in terms of acid control and efficacy” and claimed that Nexium was more effective in acid inhibition than other comparable drugs and provided relief in a shorter period of time. Nexium advertisements directed to physicians claimed that the new drug was more powerful than Prilosec, stating “we’ve captured the essence of Prilosec and created a new PPI (proton pump inhibitor)introducing Nexium, the powerful new PPI from the makers of Prilosec .
